Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging

Stefanie Hiltbrunner, Michael Mints, Maria Eldh, Robert Rosenblatt, Benny Holmström, Farhood Alamdari, Markus Johansson, Rosanne E Veerman, Ola Winqvist, Amir Sherif, Susanne Gabrielsson

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)

Abstract

Invasive urinary bladder cancer shows high recurrence rates after cystectomy even with apparent complete downstaging at cystectomy. Exosomes are nano-sized vesicles important in cell-cell communication, which have been hypothesized to contribute to cancer dissemination and recurrence. The aim of this study was to investigate if pro-carcinogenic exosomes could be detected in urine from histologically downstaged bladder cancer patients. 13 Patients were included in this study. Paired ureter and urine samples from nine patients underwent mass spectrometry, while samples from the remaining patients were used for exosome characterization. At cystectomy, exosomes were isolated from bladder and ureter urine, whereafter quantitative proteome profiling was performed. Urinary exosomes clustered based on whether they came from the bladder, with tumour contact, or the ureters, without tumour contact, even though all came from completely downstaged patients. Proteins overexpressed in exosomes derived from bladder urine contained several oncogenes and were mainly associated with tumour metabolism pathways. Although patients were histologically tumour-free at cystectomy, the bladder urine contained exosomes with a carcinogenic metabolic profile. This suggests a continuous release of exosomes from the bladder, which may promote recurrence at distant sites through metabolic rewiring, even after apparent complete downstaging. These exosomes, coming from either undetected cancer cells or partly transformed cells, are likely to increase the risk of metastasis and encourages cystectomy even in completely downstaged patients.
Original languageEnglish
Article number5960
JournalScientific Reports
Volume10
Issue number1
DOIs
Publication statusPublished - 1 Dec 2020
Externally publishedYes

Funding

We would like to acknowledge the dedicated contributions of our late colleague Dr Johan Hansson, Centre for Research and Development, Faculty of Medicine, Uppsala University, County Council of Gävleborg, to this work. We would like to acknowledge our late colleague Dr Janos Vasko, Department of Medical Biosciences, Pathology, Umeå University, for the dedicated contributions to this work. We would like to thank Kjell Hultenby, Department of Pathology, Karolinska Hospital Huddinge for the electron microscopy pictures. Research nurses Britt-Inger Dahlin and Kerstin Almroth (Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University) were of valuable assistance in the work. This work was supported by grants from the Swedish Medical Research Council VR K2013-67X-15242-10-5 and 2018-02806, The Swedish Cancer Foundation 2016/469, The Cancer Research Foundations of Radiumhemmet 131082 and 181103, The Stockholm County Council 20140405, The Swedish Heart-Lung Foundation 20140497, 20140711, 20130551, The Cancer and Allergy Foundation, the KID grant of the Karolinska Institute, The Regional research committee in the Uppsala-Örebro region (RFR in Uppsala-Örebro), the Swedish Research Council funding for clinical research in medicine (ALF) in Västerbotten, VLL, Sweden and the Cancer Research Foundation in Norrland, Umeå, Sweden. Open access funding provided by Karolinska Institute.

All Science Journal Classification (ASJC) codes

  • General

Fingerprint

Dive into the research topics of 'Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging'. Together they form a unique fingerprint.

Cite this